Yi Shu-hong, Chen Gui-hua, Lu Min-qiang, Yang Yang, Cai Chang-jie, Xu Chi, Li Hua, Wang Gen-shu, Yi Hui-min
Liver Transplantation Center, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China.
Zhonghua Wai Ke Za Zhi. 2006 Jul 1;44(13):885-8.
To explore the treatment and appropriate management of invasive aspergillosis infection following orthotopic liver transplantation.
The clinical data of 576 cases who underwent orthotopic liver transplantation consecutively between January 2000 and January 2005 were analyzed retrospectively.
The prevalence of invasive aspergillosis infection was 1.74 (9/576), included 8 cases with pulmonary aspergillosis and 1 case with cerebral aspergillosis. The interval between transplantation and diagnosis were from 10 days to 2 months. Persistent or discontinuous low fever maybe the main clinical presentation after operation. Liposomal amphotericin B (AmBisome) is the mainly treatment for invasive aspergillosis infections, 5 patients were cured and 2 patients developed multi-organ aspergillosis infection died.
The clinical features of invasive aspergillosis infection following orthotopic liver transplantation were un-typical presentations in the early stage and easy to disseminate. Appropriate modification of immunosuppression therapy and early, high dose and long-term application of antifungal treatment is effective and safe to cure the disease.
探讨原位肝移植术后侵袭性曲霉感染的治疗及合理管理。
回顾性分析2000年1月至2005年1月连续行原位肝移植的576例患者的临床资料。
侵袭性曲霉感染的发生率为1.74%(9/576),其中肺部曲霉病8例,脑曲霉病1例。移植至诊断的间隔时间为10天至2个月。术后持续或间断低热可能是主要临床表现。脂质体两性霉素B(安必素)是侵袭性曲霉感染的主要治疗药物,5例治愈,2例发生多器官曲霉感染死亡。
原位肝移植术后侵袭性曲霉感染的临床特点为早期表现不典型且易播散。适当调整免疫抑制治疗,早期、大剂量、长期应用抗真菌治疗对治愈该病有效且安全。